Type II JAK2 Inhibitor NVP-CHZ868 Is Active in Vivo Against JAK2-Dependent B-Cell Acute Lymphoblastic Leukemias (B-ALLs)
Year: 2014
Type: article
Source: Blood
Authors: Loretta S. Li, Shuo-Chieh Wu, Nadja Kopp, Joan Montero, Jeremy Ryan, Bjoern Chapuy, Jordy C. Van der Zwet, Jacob Layer, Oliver Weigert, Amanda L Christie, Alexandra N. Christodoulou, Huiyun Liu, Akinori Yoda, Francesco Hofmann, Fabienne Baffert, Eric Vangrevelinghe, Christoph Gaul, Thomas Radimerski, Anthony G. Letai, David M. Weinstock
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2556949782